How many studies have been conducted on Duocarmycins?

BiohacksAI has indexed 95 PubMed studies on Duocarmycins. 6% of studies involve human subjects.

What are the main research areas for Duocarmycins?

The primary research domains for Duocarmycins are 🔬 Oncology, 🧠 Focus & Attention, 🫁 Liver & Detox. This is based on analysis of 95 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Duocarmycins

A group of pyrroloindole compounds often with additional spirocyclic unit(s) and their analogs originally isolated from STREPTOMYCES. They bind DNA minor grooves with adenine-N3 alkylation activity.

95+ PubMed studies analyzed · Evidence Score: 36.2

Research Domains

Duocarmycins has been studied across 5 research domains including 🔬 Oncology, 🧠 Focus & Attention, 🫁 Liver & Detox, 🧬 Hormones, 🦠 Gut & Microbiome. The primary research focus is 🔬 Oncology with 54% of studies addressing this area.

Loading evidence profile...

This evidence profile for Duocarmycins is generated deterministically from 95 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.